AbbVie registers Phase 3 trial of telisotuzumab adizutecan in NSCLCSep 16Trial updateAbbVietelisotuzumab adizutecan
Lilly registers Phase 3 depression trial; posts results for two psoriasis and oncology studiesAug 20Weekly roundup, 5 itemsabemaciclibbrenipatide
Ascentage Pharma names new Chief Business Officer and Chief Commercial OfficerAug 3PeopleAscentage Pharma Group International
Sign inSign in